Registro:

Referencias:

• Smith, S.M., Vale, W.W., The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress (2006) Dialogues Clin. Neurosci., 8, pp. 383-395. , &
• De Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: From adaptation to disease (2005) Nat. Rev. Neurosci., 6, pp. 463-475. , &
• Hillhouse, E.W., Grammatopoulos, D.K., The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: Implications for physiology and pathophysiology (2006) Endocr. Rev., 27, pp. 260-286. , &
• Besedovsky, H.O., Del Rey, R.A., Immune-neuro-endocrine interactions: Facts and hypotheses (1996) Endocr. Rev., 17, pp. 64-102. , &
• Branda, C.S., Dymecki, S.M., Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice (2004) Dev. Cell, 6, pp. 7-28. , &
• Deussing, J.M., Wurst, W., Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour (2005) C.R. Biol., 328, pp. 199-212. , &
• Bale, T.L., Vale, W.W., CRF and CRF receptors: Role in stress responsivity and other behaviors (2004) Annu. Rev. Pharmacol. Toxicol., 44, pp. 525-557. , &
• Herman, J.P., Figueiredo, H., Mueller, N.K., Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness (2003) Front Neuroendocrinol., 24, pp. 151-180
• Korosi, A., Baram, T.Z., The central corticotropin releasing factor system during development and adulthood (2008) Eur. J. Pharmacol., 583, pp. 204-214. , &
• Smagin, G.N., Heinrichs, S.C., Dunn, A.J., The role of CRH in behavioral responses to stress (2001) Peptides, 22, pp. 713-724. , &
• Arborelius, L., Owens, M.J., Plotsky, P.M., The role of corticotropin-releasing factor in depression and anxiety disorders (1999) J. Endocrinol., 160, pp. 1-12
• Buzzetti, R., McLoughlin, L., Lavender, P.M., Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies (1989) J. Clin. Invest., 83, pp. 733-737
• Lyons, P.D., Blalock, J.E., Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes (1997) J. Neuroimmunol., 78, pp. 47-56. , &
• Cabot, P.J., Carter, L., Gaiddon, C., Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats (1997) J. Clin. Invest., 100, pp. 142-148
• Smith, E.M., Blalock, J.E., Human lymphocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 7530-7534. , &
• Kavelaars, A., Ballieux, R.E., Heijnen, C.J., The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells (1989) J. Immunol., 142, pp. 2338-2342. , &
• Blalock, J.E., Beta-endorphin in immune cells (1998) Immunol. Today, 19, pp. 191-192
• Panerai, A.E., Sacerdote, P., Beta-endorphin in the immune system: A role at last? (1997) Immunol. Today, 18, pp. 317-319. , &
• Apte, R.N., Durum, S.K., Oppenheim, J.J., Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages (1990) Immunol. Lett., 24, pp. 141-148. , &
• Hosoi, J., Ozawa, H., Granstein, R.D., Beta-Endorphin binding and regulation of cytokine expression in Langerhans cells (1999) Ann. N. Y. Acad. Sci., 885, pp. 405-413. , &
• Kovalovsky, D., Pereda, M.P., Stalla, G.K., Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and beta-endorphin (1999) Neuroimmunomodulation, 6, pp. 367-372
• Belkowski, S.M., Alicea, C., Eisenstein, T.K., Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H (1995) J. Pharmacol. Exp. Ther., 273, pp. 1491-1496
• Chao, C.C., Molitor, T.W., Close, K., Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures (1993) Int. J. Immunopharmacol., 15, pp. 447-453
• Fontana, L., Fattorossi, A., D'Amelio, R., Modulation of human concanavalin A-induced lymphocyte proliferative response by physiological concentrations of beta-endorphin (1987) Immunopharmacology, 13, pp. 111-115
• Gilmore, W., Weiner, L.P., The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation (1989) Immunopharmacology, 17, pp. 19-30. , &
• Van Den Bergh, P., Rozing, J., Nagelkerken, L., Two opposing modes of action of beta-endorphin on lymphocyte function (1991) Immunology, 72, pp. 537-543. , &
• Puppo, F., Corsini, G., Mangini, P., Influence of beta-endorphin on phytohemagglutinin-induced lymphocyte proliferation and on the expression of mononuclear cell surface antigens in vitro (1985) Immunopharmacology, 10, pp. 119-125
• Panerai, A.E., Manfredi, B., Granucci, F., The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/autocrine effects of the opioid (1995) J. Neuroimmunol., 58, pp. 71-76
• Rubinstein, M., Mogil, J.S., Japon, M., Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 3995-4000
• Refojo, D., Kovalovsky, D., Young, J.I., Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice (2002) J. Neuroimmunol., 131, pp. 126-134
• Swanson, L.W., Sawchenko, P.E., Rivier, J., Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study (1983) Neuroendocrinology, 36, pp. 165-186
• Grigoriadis, D.E., The corticotropin-releasing factor receptor: A novel target for the treatment of depression and anxiety-related disorders (2005) Expert. Opin. Ther. Targets, 9, pp. 651-684
• Holsboer, F., Ising, M., Central CRH system in depression and anxiety - Evidence from clinical studies with CRH1 receptor antagonists (2008) Eur. J. Pharmacol., 583, pp. 350-357. , &
• Todorovic, C., Jahn, O., Tezval, H., The role of CRF receptors in anxiety and depression: Implications of the novel CRF1 agonist cortagine (2005) Neurosci. Biobehav. Rev., 29, pp. 1323-1333
• Bittencourt, J.C., Sawchenko, P.E., Do centrally administered neuropeptides access cognate receptors?: An analysis in the central corticotropin-releasing factor system (2000) J. Neurosci., 20, pp. 1142-1156. , &
• Van Pett, K., Viau, V., Bittencourt, J.C., Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse (2000) J. Comp Neurol., 428, pp. 191-212
• Hauger, R.L., Risbrough, V., Brauns, O., Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets (2006) CNS Neurol. Disord. Drug Targets, 5, pp. 453-479
• Timpl, P., Spanagel, R., Sillaber, I., Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 (1998) Nat. Genet., 19, pp. 162-166
• Smith, G.W., Aubry, J.M., Dellu, F., Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development (1998) Neuron, 20, pp. 1093-1102
• Arzt, E., Holsboer, F., CRF signaling: Molecular specificity for drug targeting in the CNS (2006) Trends Pharmacol. Sci., 27, pp. 531-538. , &
• Philips, A., Lesage, S., Gingras, R., Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells (1997) Mol. Cell Biol., 17, pp. 5946-5951
• Kovalovsky, D., Refojo, D., Liberman, A.C., Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: Involvement of calcium, protein kinase A, and MAPK pathways (2002) Mol. Endocrinol., 16, pp. 1638-1651
• Brar, B.K., Chen, A., Perrin, M.H., Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides (2004) Endocrinology, 145, pp. 1718-1729
• Grammatopoulos, D.K., Randeva, H.S., Levine, M.A., Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: An effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins (2000) Mol. Endocrinol., 14, pp. 2076-2091
• Bayatti, N., Zschocke, J., Behl, C., Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons (2003) Endocrinology, 144, pp. 4051-4060. , &
• Elliott-Hunt, C.R., Kazlauskaite, J., Wilde, G.J., Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus (2002) J. Neurochem., 80, pp. 416-425
• Swinny, J.D., Metzger, F., Ijkema-Paassen, J., Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro (2004) Eur. J. Neurosci., 19, pp. 1749-1758
• Di Benedetto, B., Hitz, C., Holter, S.M., Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain (2007) J. Comp Neurol., 500, pp. 542-556
• Ailing, F., Fan, L., Li, S., Role of extracellular signal-regulated kinase signal transduction pathway in anxiety (2008) J. Psychiatr. Res., 43, pp. 55-63
• Meller, E., Shen, C., Nikolao, T.A., Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases (2003) Brain Res., 979, pp. 57-64
• Einat, H., Yuan, P., Gould, T.D., The role of the extracellular signal-regulated kinase signaling pathway in mood modulation (2003) J. Neurosci., 23, pp. 7311-7316
• Duman, C.H., Schlesinger, L., Kodama, M., A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment (2007) Biol. Psychiatry, 61, pp. 661-670
• Tronson, N.C., Schrick, C., Fischer, A., Regulatory mechanisms of fear extinction and depression-like behavior (2008) Neuropsychopharmacology, 33, pp. 1570-1583
• Refojo, D., Echenique, C., Muller, M.B., Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 6183-6188
• Muller, M.B., Zimmermann, S., Sillaber, I., Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress (2003) Nat. Neurosci., 6, pp. 1100-1107
• Qi, X., Lin, W., Li, J., The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress (2006) Behav. Brain Res., 175, pp. 233-240
• Dwivedi, Y., Rizavi, H.S., Roberts, R.C., Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects (2001) J. Neurochem., 77, pp. 916-928
• Di Benedetto, B., Kallnik, M., Weisenhorn, D.M., Activation of ERK/MAPK in the Lateral Amygdala of the Mouse is Required for Acquisition of a Fear-Potentiated Startle response (2008) Neuropsychopharmacology, , In press
• Fischer, A., Radulovic, M., Schrick, C., Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior (2007) Neurobiol. Learn. Mem., 87, pp. 149-158
• Berton, O., Nestler, E.J., New approaches to antidepressant drug discovery: Beyond monoamines (2006) Nat. Rev. Neurosci., 7, pp. 137-151. , &
• Nemeroff, C.B., Widerlov, E., Bissette, G., Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients (1984) Science, 226, pp. 1342-1344
• Holsboer, F., Von Bardeleben, U., Gerken, A., Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression (1984) N. Engl. J. Med., 311, p. 1127
• Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C., Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients (1994) Neuroendocrinology, 60, pp. 436-444
• Nemeroff, C.B., Owens, M.J., Bissette, G., Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims (1988) Arch. Gen. Psychiatry, 45, pp. 577-579
• Dunn, A.J., Berridge, C.W., Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? (1990) Brain Res. Brain Res. Rev., 15, pp. 71-100. , &
• Tamminga, C.A., Nemeroff, C.B., Blakely, R.D., Developing novel treatments for mood disorders: Accelerating discovery (2002) Biol. Psychiatry, 52, pp. 589-609
• Stenzel-Poore, M.P., Cameron, V.A., Vaughan, J., Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice (1992) Endocrinology, 130, pp. 3378-3386
• Groenink, L., Pattij, T., De, J.R., 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety (2003) Eur. J. Pharmacol., 463, pp. 185-197
• Tronche, F., Kellendonk, C., Kretz, O., Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety (1999) Nat. Genet., 23, pp. 99-103
• Lu, A., Steiner, M.A., Whittle, N., Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior (2008) Mol. Psychiatry, 13, pp. 1028-1042
• Hasler, G., Drevets, W.C., Manji, H.K., Discovering endophenotypes for major depression (2004) Neuropsychopharmacology, 29, pp. 1765-1781
• Van Gaalen, M.M., Reul, J.H., Gesing, A., Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge (2002) Genes Brain Behav., 1, pp. 174-177
• Steckler, T., Holsboer, F., Corticotropin-releasing hormone receptor subtypes and emotion (1999) Biol. Psychiatry, 46, pp. 1480-1508. , &

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------